Konecny G - Search Results

1

ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.

Kurbacher CM, Grecu OM, Stier U, Gilster TJ, Janát MM, Untch M, Konecny G, Bruckner HW, Cree IA. Kurbacher CM, et al. Among authors: konecny g. Recent Results Cancer Res. 2003;161:221-30. doi: 10.1007/978-3-642-19022-3_17. Recent Results Cancer Res. 2003. PMID: 12528810 Review.

2

[Use of G-CSF in dose-intensified chemotherapy of breast cancer with FEC (500/75/500 mg/m2 KO) in the adjuvant and metastatic situation].

Konecny G, Nestle-Krämling C, Untch M. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:301-2. doi: 10.1159/000272274. Gynakol Geburtshilfliche Rundsch. 1993. PMID: 7509677 German. No abstract available.

3

[Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].

Untch M, Sevin BU, Untch A, Konecny G, Nestle-Krämling C, Korell M, Hepp H. Untch M, et al. Among authors: konecny g. Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:311-3. doi: 10.1159/000272279. Gynakol Geburtshilfliche Rundsch. 1993. PMID: 7906979 German. No abstract available.

4

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Among authors: konecny g. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

5

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Lisboa BW, Untch M, Kühnle H, Jänicke F, Meerpohl HG, Lindner C, Konecny G, Hecker D, Diergarten K. Lück HJ, et al. Among authors: konecny g. Semin Oncol. 1997 Feb;24(1 Suppl 3):S13-6. Semin Oncol. 1997. PMID: 9071334 Clinical Trial.

6

[New drugs in therapy of breast carcinoma: current status and outlook].

Konecny G, Untch M, Hepp H. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 1997;37(2):54-61. doi: 10.1159/000272832. Gynakol Geburtshilfliche Rundsch. 1997. PMID: 9445630 Review. German.

7

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.

Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M. Konecny G, et al. Gynecol Oncol. 2000 May;77(2):258-63. doi: 10.1006/gyno.2000.5728. Gynecol Oncol. 2000. PMID: 10785475

8

[Retrospective analysis of dose intensity of epirubicin in breast cancer].

Konecny G, Frank M, Kahlert S, Untch M, Hepp H. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 2000;40(3-4):145-52. doi: 10.1159/000053017. Gynakol Geburtshilfliche Rundsch. 2000. PMID: 11326159 German.

9

Dose-dense and sequential strategies in adjuvant breast cancer therapy.

Untch M, Von Koch F, Crohns C, Sobotta K, Kahlert S, Konecny G, Hepp H. Untch M, et al. Among authors: konecny g. Oncology (Williston Park). 2001 May;15(5 Suppl 7):14-20. Oncology (Williston Park). 2001. PMID: 11396359 Free article. Review.

10

Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.

Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, Slamon D, Pegram M. Konecny G, et al. Clin Cancer Res. 2001 Jun;7(6):1743-9. Clin Cancer Res. 2001. PMID: 11410515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters